Suche Forschungsprojekt
Weitere Suchoptionen
32 Ergebnis(se)
Förderung durch ein IRDiRC-Mitglied = 
ERN-Mitglied = 
Forschungsprojekt(e)
OSTERREICH
OBERÖSTERREICH
LINZ
EuRR-Bone: European Registry for Rare Bone and Mineral Conditions - AT
Kepler Universitätsklinikum - Med Campus IV.
Universitätsklinik für Kinder- und Jugendheilkunde
SCHWEIZ
Suisse Alémanique
BASEL
Bone prefabrication for osteonecrosis
Universitätsspital Basel
Department of Biomedicine
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Novel mri methods for osteochondritis dissecans (ocd) / osteochondrosis (oc)
Institution: Information not provided - US
DEUTSCHLAND
Hamburg
HAMBURG
Multizentrische prospektive Kohortenstudie zu aktuellen Behandlungsmethoden der Legg-Calvé-Perthes-Krankheit
AKK Altonaer Kinderkrankenhaus gGmbH
Fachabteilung für Kinderorthopädie
DEUTSCHLAND
Schleswig-Holstein
LÜBECK
Multizentrische prospektive Kohortenstudie zu aktuellen Behandlungsmethoden der Legg-Calvé-Perthes-Krankheit
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Klinik für Orthopädie und Unfallchirurgie - Sektion für Orthopädie
ITALIEN
LOMBARDIA
MILANO
Evaluation of Polymorphisms in the Vitamin D Receptor and Involved in Inflammation Associated With Vertebral Osteochondrosis
I.R.C.C.S Istituto Ortopedico Galeazzi
IRCCS Istituto Ortopedico Galeazzi
BELGIEN
ANTWERPEN
EDEGEM (ANTWERPEN)
BETCON: A Multicenter Randomized Controlled Open-label Trial of Conservative Management Versus Minimally Invasive Treatment With Leukocyte- and Platelet-rich Fibrin Versus Primary Surgery in Patients With Newly Diagnosed Osteonecrosis of the Jaw - BE
University Hospital Antwerp - UZA
Nucleaire geneeskunde - UZA
SPANIEN
Cataluńa
BARCELONA
Translation of an allogenic tissue engineering product with MSC from Wharton's jelly for the treatment of osteonecrosis in paediatric oncology patients
Vall d'Hebron Institut de Recerca VHIR
Grupo de investigación en Ingeniería Tisular Musculoesquelética
FINNLAND
Finland
HELSINKI
Genomic editing for treating hemoglobin diseases
University of Helsinki
Stem Cells and Metabolism Research Program
FRANKREICH
ILE-DE-FRANCE
PARIS
Non-invasive prenatal diagnosis of sickle cell anemia by next generation sequencing (NGS)
CHU Paris - Hôpital Robert Debré
UF de Génétique Moléculaire
FRANKREICH
ILE-DE-FRANCE
PARIS
Constitutive hematologic diseases: clinical and therapeutic research, molecular biology
GHU AP-HP Nord. Université de Paris - Hôpital Saint-Louis
Service d'hématologie pédiatrique
FRANKREICH
ILE-DE-FRANCE
PARIS
CRISPR/Cas9 mediated induction of fetal hemoglobin synthesis for the treatment of beta-hemoglobinopathies
IMAGINE - Institut des Maladies Génétiques
Institut IMAGINE - INSERM U1163
FRANKREICH
ILE-DE-FRANCE
PARIS
Development of Innovative Therapeutic Strategies for Beta-Hemoglobinopathies
IMAGINE - Institut des Maladies Génétiques
Institut IMAGINE - INSERM U1163
FRANKREICH
ILE-DE-FRANCE
PARIS
Improvement of gene therapy strategies based on the use of hematopoietic stem cells for the treatment of ß-hemoglobinopathies
IMAGINE - Institut des Maladies Génétiques
Institut IMAGINE - INSERM U1163
ITALIEN
LAZIO
ROMA
Advances in diagnosis of thalassemia and haemoglobinopathies: development of innovative techniques by thermogravimetry coupled with chemometrics
ISS - Istituto Superiore di Sanitŕ
Centro Nazionale per la Ricerca e la Valutazione preclinica e clinica dei Farmaci
OSTERREICH
WIEN
ADDRESS: NOT PROVIDED - AT
Adakveo (crizanlizumab) PRegnancy outcomes Intensive Monitoring (PRIM) - AT
Institution: Information not provided - AT
PORTUGAL
NORTE
PORTO
The sorting and trafficking of lysosomal proteins through M6P independent pathways: molecular, biochemical and functional studies
Instituto Nacional de Saúde Dr. Ricardo Jorge - Porto
Unidade de Investigaçăo & Desenvolvimento; Departamento de Genética
PORTUGAL
SUL
LISBOA
Development and validation of vaso-occlusion early predictors in mendelian model of vascular disease
Instituto Nacional de Saúde Dr. Ricardo Jorge - Lisboa
Departamento de Genética
SPANIEN
Cataluńa
BARCELONA
Enabling personalized medicine of sickle cell disease patients based on integrative diagnosis of new generation methodologies
Vall d'Hebron Institut de Recerca VHIR
Vall d'Hebron Institut de Recerca
VEREINIGTE STAATEN
North Carolina
CHAPEL HILL
Prospective Study in Sickle Cell Anemia: Determine Biomarkers of Endothelial Function Changes in Chronic Kidney Disease
University of North Carolina
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Therapeutics for rare and neglected diseases - science
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Preclinical innovation
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Genetic epidemiology of complex traits
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Insights into sickle cell trait and sickle cell disease
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Red cell biology
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Understanding the relationships between race; ethnicity; ancestry and genomics
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Neuro-ophthalmic mechanisms of disease
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
The impact of childhood chronic disease on child patient reported outcomes
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Mri-based quantitative brain oxygen metabolism identifying high risk of infarct recurrence in sickle cell anemia
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Age-dependence of cerebral oxygen metabolism and stroke risk in pediatric sickle cell disease
Institution: Information not provided - US
Multizentrische Forschungsprojekte
- Groupe hospitalier AP-HP.6 - Hôpital Tenon
- Laboratoire d'Hémostase et de Thrombose
- The Cyprus Institute of Neurology and Genetics
- Department of molecular genetics A
FRANKREICH
ILE-DE-FRANCE
PARIS
Clinical research network on sickle cell anemia
ZYPERN
Cyprus
NICOSIA